By staff writers

June 17, 2019 -- Cochlear Limited has received U.S. Food and Drug Administration (FDA) clearance for use of its Nucleus Profile Plus cochlear implant in 1.5- and 3-tesla MRI systems.

The Nucleus Profile Plus allows patients to undergo an MRI exam without the need to remove the implant's internal magnet or use a head wrap, Cochlear Limited said.

The FDA has also cleared Cochlear Limited's Nucleus 7 sound processor for cochlear implants. The device enables direct audio streaming from Apple and Android smartphones without attaching any additional intermediary devices.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking